Connection

David Smadja to Endothelial Cells

This is a "connection" page, showing publications David Smadja has written about Endothelial Cells.
Connection Strength

1.325
  1. Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity. Angiogenesis. 2019 05; 22(2):325-339.
    View in: PubMed
    Score: 0.352
  2. Forearm ischemia decreases endothelial colony-forming cell angiogenic potential. Cytotherapy. 2014 Feb; 16(2):213-24.
    View in: PubMed
    Score: 0.247
  3. Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening. PLoS One. 2013; 8(6):e65114.
    View in: PubMed
    Score: 0.240
  4. [Characterization of endothelial progenitor cells and putative strategies to improve their expansion]. J Soc Biol. 2009; 203(2):197-207.
    View in: PubMed
    Score: 0.182
  5. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis. 2021 11; 24(4):755-788.
    View in: PubMed
    Score: 0.105
  6. Curative anticoagulation prevents endothelial lesion in COVID-19 patients. J Thromb Haemost. 2020 09; 18(9):2391-2399.
    View in: PubMed
    Score: 0.098
  7. Human endoglin as a potential new partner involved in platelet-endothelium interactions. Cell Mol Life Sci. 2018 04; 75(7):1269-1284.
    View in: PubMed
    Score: 0.081
  8. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. Expert Opin Ther Targets. 2017 10; 21(10):933-947.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.